| 349 |
Inhibition of 11β-hydroxylase leading to decresed population trajectory |
Young Jun Kim |
BY-SA |
1796: 11β-hydroxylase inhibition
|
360: Decrease, Population growth rate
|
Under Development |
1.93 |
| 263 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
WPHA/WNT Endorsed |
1.92 |
| 264 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via ATP depletion associated cell death |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 265 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via increased cytosolic calcium |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 266 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased Na-K ATPase activity |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 267 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via glucose depletion |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 268 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via mitochondrial swelling |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
Under Development |
1.92 |
| 442 |
Binding to voltage gate sodium channels during development leads to cognitive impairment |
Iris Mangas |
BY-SA |
1353: Binding to voltage-gated sodium channel
|
402: Cognitive function, decreased
|
WPHA/WNT Endorsed |
1.91 |
| 305 |
5α-reductase inhibition leading to short anogenital distance (AGD) in male (mammalian) offspring |
Terje Svingen |
BY-SA |
1617: Inhibition, 5α-reductase
|
1688: anogenital distance (AGD), decreased
|
Under Review |
1.90 |
| 306 |
Androgen receptor (AR) antagonism leading to short anogenital distance (AGD) in male (mammalian) offspring |
Terje Svingen |
BY-SA |
26: Antagonism, Androgen receptor
|
1688: anogenital distance (AGD), decreased
|
Under Review |
1.90 |
| 307 |
Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring |
Terje Svingen |
BY-SA |
None
|
1688: anogenital distance (AGD), decreased
|
Under Review |
1.90 |
| 8 |
Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Katie Paul Friedman |
Open for adoption |
239: Activation, Pregnane-X receptor, NR1I2
|
319: Loss, Cochlear function
|
Under Development |
1.9 |
| 483 |
Deposition of Energy Leading to Learning and Memory Impairment |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
341: Impairment, Learning and memory
|
WPHA/WNT Endorsed |
1.89 |
| 478 |
Deposition of energy leading to occurrence of cataracts |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2083: Occurrence of Cataracts
|
WPHA/WNT Endorsed |
1.89 |
| 482 |
Deposition of energy leading to occurrence of bone loss |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2091: Occurrence, Bone Loss
|
WPHA/WNT Endorsed |
1.89 |
| 470 |
Deposition of energy leads to abnormal vascular remodeling |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2069: Occurrence, Abnormal Vascular Remodeling
|
WPHA/WNT Endorsed |
1.89 |
| 302 |
Lung surfactant function inhibition leading to decreased lung function |
Jorid Birkelund Sørli |
BY-SA |
1672: Inhibition of lung surfactant function
|
1250: Decrease, Lung function
|
Under Development |
1.87 |
| 303 |
Frustrated phagocytosis-induced lung cancer |
Carole Seidel |
BY-SA |
1668: Frustrated phagocytosis
|
1670: Lung cancer
|
Under Development |
1.86 |
| 300 |
Thyroid Receptor Antagonism and Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Kevin Crofton |
BY-SA |
1656: Antagonism, Thyroid Receptor
|
402: Cognitive function, decreased
|
Under Development |
1.84 |
| 289 |
Inhibition of 5α-reductase leading to impaired fecundity in female fish |
Young Jun Kim |
BY-SA |
1617: Inhibition, 5α-reductase
|
360: Decrease, Population growth rate
|
Under Development |
1.81 |
| 293 |
Increased DNA damage leading to increased risk of breast cancer |
Jessica Helm |
BY-SA |
1194: Increase, DNA damage
|
3 AOs
|
Under Development |
1.80 |
| 294 |
Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer |
Jessica Helm |
BY-SA |
1632: Increase in reactive oxygen and nitrogen species (RONS)
|
4 AOs
|
Under Development |
1.80 |
| 46 |
AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC) |
Ted Simon |
BY-SA |
373: Formation, Pro-mutagenic DNA Adducts
|
378: Tumorigenesis, Hepatocellular carcinoma
|
Under Review |
1.8 |
| 295 |
Early-life stromal estrogen receptor activation by endocrine disrupting chemicals in the mammary gland leading to enhanced cancer risk |
Andrea Hindman |
BY-SA |
None
|
None
|
Under Development |
1.79 |
| 292 |
Inhibition of tyrosinase leads to decreased population in fish |
Young Jun Kim |
BY-SA |
1627: Inhibition of tyrosinase
|
360: Decrease, Population growth rate
|
Under Development |
1.78 |